London stocks were still a touch higher by midday on Wednesday as investors continued to mull the impact of Trump’s trade war ...

UK stocks are moving in a tight band Wednesday morning with investors largely focusing on earnings updates, and digesting the data on ...

London stocks edged higher on Wednesday as investors weighed the ongoing effects of trade tensions linked to US president ...

GSK’s global performance showed strength across key markets. Sales in the United States reached £16.4 billion, up 6% at ...

European markets opened mixed on Wednesday, with investors looking ahead to more earnings from a number of key companies.

GSK has reported a 7% increase in full-year revenue for 2024, reaching £31.4 billion ($39.3 billion), slightly surpassing market expectations. The fourth quarter contributed £8.1 billion, a 4% rise ...

Real-time index price for Nasdaq Global Select Market Composite Index (NQGS), along with buy or sell indicators, analysis, ...

Banco Santander (BME: SAN) shares spiked over 6% on Wednesday after the lender unveiled plans for €10 billion (£8.3 billion) ...

Mike Ralston, CEO of Blencowe Resources (BRES) and Manuel Pablo Zúñiga-Pflücker, President and CEO of PetroTal (PTAL) will be presenting and taking live Q&A at focusIR's Investor Webinar on Tuesday ...

European shares ended Wednesday's choppy session higher, as a rise in healthcare companies GSK and Novo Nordisk following ...

Wall Street was mostly lower on Wednesday despite US employment growth picking up last month by more than expected.

GSK plc GSK reported fourth-quarter 2024 core earnings of 59 cents per American depositary share (ADS), which beat the Zacks ...